Skip to main content
. 2023 Jun 6;330(1):33–42. doi: 10.1001/jama.2023.9106

Figure 3. Leukopenia or Neutropenia Events and Time to Onset Through Week 28 in the Safety Population.

Figure 3.

aAll participants in the letermovir group received acyclovir for prophylaxis of herpes simplex and varicella zoster virus.

bParticipants were only counted once for the composite safety outcome of ≥1 leukopenia or neutropenia event. P < .001. P value and 95% CI based on the Miettinen and Nurminen method.

cNumber of events is shown by time period: day 1 to week 14, week 14 to week 28, and week 28 to 14 days after prophylaxis was completed. Data were censored at the time of last assessment.